A number of different alterations of cell signaling molecules have been found to promote angiogenesis/growth in GBM, including increased signaling from Vascular Endothelial Growth Factor receptor (VEGFR), Epidermal Growth Factor receptor (EGFR) [26] and Platelet–derived Growth Factor (PDGF) [2]. This evidence concerns the gene KDR and glioblastoma.